Strong Q3 EBITDA and Large Sequential Improvement
Group EBITDA in Q3 reached EUR 60.2 million, up from EUR 8.2 million in Q3 last year (≈+634% year‑over‑year) and up from EUR 30.1 million in the prior quarter (≈+100% quarter‑over‑quarter). The Bioethanol/Biomethane segment was the main driver of the Q3 improvement.
Full‑Year EBITDA Guidance Raised to Upper End
Management now expects full‑year EBITDA at the upper end of the previously announced EUR 100–140 million guidance range (i.e., toward ~EUR 140 million). Net financial debt is expected to be below EUR 140 million at year‑end and management targets net debt‑to‑EBITDA below 1.
Production Ramp‑Up and Record Volumes in Key Areas
Year‑to‑date production: biodiesel ~458,000 tonnes (broadly flat vs prior year), bioethanol ~431,000 tonnes (increase year‑on‑year), and biomethane exceeded 1 TWh for the first time after 9 months. Q3 biodiesel production increased quarter‑over‑quarter to 147,000 tonnes. Ramp‑up in Nevada (bioethanol/biomethane) and continued ramp in Iowa support higher volumes.
Segment Profitability — Bioethanol/Biomethane and Biodiesel
Bioethanol/Biomethane segment delivered Q3 EBITDA of EUR 34.2 million (driven by tighter GHG quota market and seasonal demand). Biodiesel segment produced a solid Q3 EBITDA of EUR 18.5 million despite weaker mid‑quarter market conditions.
Improved Operating Cash Flow and Positive Free Cash Flow
Year‑to‑date operating cash flow of EUR 96.4 million (operating cash swing > EUR 100 million). Investments in PPE totaled EUR 63.4 million, with positive free cash flow of EUR 33 million after 9 months. Net debt decreased to EUR 126.8 million and equity ratio improved to 59.3%.
Regulatory Tailwinds — RED III and U.S. RVO
Final implementation of RED III in Germany (Bundesrat approval May 8) and the largest U.S. Renewable Volume Obligations for 2026/27 materially strengthen structural demand. Quota levels rise materially (cited to ~17.5% and ~19.5% for 2027/28), increasing required real CO2 savings from ~20 million tpa to roughly 35–40 million tpa and removing double counting — supportive for long‑term physical demand for compliant biofuels.
Material Sensitivity of EBITDA to GHG Quota Prices
Management disclosed that a EUR 100 increase in GHG quota prices could affect annual EBITDA by approximately EUR 40–80 million, underlining meaningful leverage to quota price movements.
Commercial Upside from International Markets
U.S. market developments (RVO) and attractive blending economics support export demand and potential winter production upside for the Canadian plant; expansion projects (ethenolysis plant in final construction phase; commissioning targeted in October) and broader international activity were reiterated.